Fludarabine phosphate in lymphoma: an important new therapeutic agent.
McLaughlin, P
Fludarabine phosphate in lymphoma: an important new therapeutic agent. [electronic resource] - Cancer treatment and research 1996 - 3-14 p. digital
Publication Type: Journal Article; Review
0927-3042
10.1007/978-1-4615-4129-5_1 doi
Antimetabolites, Antineoplastic--therapeutic use
Clinical Trials, Phase I as Topic
Clinical Trials, Phase II as Topic
Hodgkin Disease--drug therapy
Humans
Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy
Lymphoma--drug therapy
Multiple Myeloma--drug therapy
Vidarabine Phosphate--analogs & derivatives
Waldenstrom Macroglobulinemia--drug therapy
Fludarabine phosphate in lymphoma: an important new therapeutic agent. [electronic resource] - Cancer treatment and research 1996 - 3-14 p. digital
Publication Type: Journal Article; Review
0927-3042
10.1007/978-1-4615-4129-5_1 doi
Antimetabolites, Antineoplastic--therapeutic use
Clinical Trials, Phase I as Topic
Clinical Trials, Phase II as Topic
Hodgkin Disease--drug therapy
Humans
Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy
Lymphoma--drug therapy
Multiple Myeloma--drug therapy
Vidarabine Phosphate--analogs & derivatives
Waldenstrom Macroglobulinemia--drug therapy